Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.
Clinical trial NCT06247735 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06247735
- Sponsor
- Kowa Research Institute, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-07
- Primary completion
- 2025-06-26
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.